Cyp2c19 Genotype

CYP2C19 Genotype is a genetic profile defining the specific allelic variants of the CYP2C19 gene that determine an individual's capacity for metabolizing certain drugs, particularly relevant in pediatric pharmacogenomics for predicting variable drug responses.

1.3K

Publications

75.7K

Citations

7.5K

Authors

1.9K

Institutions

Publications per year

2017–2026

317

Authors

7.5K

  1. TF
    Takahisa Furuta

    Hamamatsu University School of Medicine, Japan

    33 publications · 3K citations

    26

    h-index

  2. TI
    Takashi Ishizaki

    Tokyo Medical Center, Japan

    29 publications · 2.8K citations

    25

    h-index

  3. NS
    Naohito Shirai

    Hamamatsu University School of Medicine, Japan

    20 publications · 1.6K citations

    19

    h-index

  4. AG
    Andrea Gaedigk

    Children's Mercy Hospital, United States

    17 publications · 3.3K citations

    15

    h-index

  5. KN
    Kazuko Nakagawa

    Kumamoto University, Japan

    16 publications · 896 citations

    15

    h-index

1–5 of 7.5K

Venues

  1. Clinical Pharmacology & Therapeutics

    CPT · 84 publications · 12.6K citations

    53

    h-index

  2. European Journal of Clinical Pharmacology

    72 publications · 3.2K citations

    35

    h-index

  3. British Journal of Clinical Pharmacology

    BJCP · 49 publications · 2.5K citations

    30

    h-index

  4. Pharmacogenetics

    30 publications · 2.9K citations

    25

    h-index

  5. Therapeutic Drug Monitoring

    27 publications · 1.4K citations

    22

    h-index

1–5